Nurofen pulled from shelves as British maker found cheating in Australia

Nurofen pulled from shelves as British maker found cheating in Australia
Copyright 
By Robert Hackwill
Share this articleComments
Share this articleClose Button
Copy/paste the article video embed link below:Copy to clipboardCopied

A British pharmaceuticals giant has been forced to pull a bestselling product from the shelves in Australia after a court order. Judges ruled Reckitt

ADVERTISEMENT

A British pharmaceuticals giant has been forced to pull a bestselling product from the shelves in Australia after a court order.

Judges ruled Reckitt Benckiser misled consumers by charging nearly double the price for the Nurofen-branded common painkiller ibuprofen lysine at identical doses for specific pain such as back pain.

“Well I think consumers will be frankly extremely concerned that a company would make these claims when they’re not true. Usually we think of very large companies that are household names, they bring to their label a certain level of trust and I think this is concerning for consumers,” said the head of Australia’s Competition and Consumer Commission Rod Sims.

A separate court hearing will determine the fines imposed, and the company has also been hit by a package of penalties and increased scrutiny. More worryingly, where Australia acts others might follow.

Share this articleComments

You might also like

Britain's King Charles attends Easter service, in first public appearance since cancer diagnosis

'Slaughtered': UK farmers protest post-Brexit rules and trade deals

Vaughan Gething elected as first minister of Wales